國立虎尾科技大學 |

Associations Between Medications, Vitamin B12, Gastrointestinal Health, Gut Microbiome and Cognitive Function.

Record Type:	Language materials, manuscript : Monograph/item
Title/Author:	Associations Between Medications, Vitamin B12, Gastrointestinal Health, Gut Microbiome and Cognitive Function./
Author:	Dinesh, Deepika C.
Description:	1 online resource (192 pages)
Notes:	Source: Dissertations Abstracts International, Volume: 85-08, Section: B.
Contained By:	Dissertations Abstracts International85-08B.
Subject:	Pharmaceutical sciences. -
Online resource:	click for full text (PQDT)
ISBN:	9798381448399

Associations Between Medications, Vitamin B12, Gastrointestinal Health, Gut Microbiome and Cognitive Function.
Dinesh, Deepika C.

Associations Between Medications, Vitamin B12, Gastrointestinal Health, Gut Microbiome and Cognitive Function. - 1 online resource (192 pages)

Source: Dissertations Abstracts International, Volume: 85-08, Section: B.

Thesis (Ph.D.)--University of Massachusetts Lowell, 2024.

Includes bibliographical references

Introduction: The burden of cognitive impairment is increasing in older adults. Recent estimates report that the largest increase in Alzheimer disease (AD) and related dementias, by 2060, will be among Hispanics and Latinos. Medication use, gastrointestinal (GI) dysfunction and gut dysbiosis are increasingly recognized as modifiable risk factors for cognitive impairment and deficiency of neuroprotective micronutrients, such as vitamin B12. These associations are under-reported in Hispanics and Latinos including Puerto Ricans.Objectives: The broad focus of this dissertation is to examine the associations of medication use, bowel health, gut microbial composition, serum biomarkers of vitamin B12 status, and cognitive function in a prospective cohort of Boston-area Puerto Ricans adults.Methods: This study utilizes cross-sectional and longitudinal data from four waves of data collection over 12 years of follow-up in the Boston Puerto Rican Health Study (BPRHS) among participants aged 45-75 years at baseline. Association between proton pump inhibitors (PPI) and cognitive function (chapter 1), and the associations between acid lowering agents (ALAs, i.e., use of PPIs or histamine type-2 receptor antagonists), metformin use, including long-term medication use, and serum vitamin B12 status are examined (chapter 2). Next, the differences in microbial composition and functions associated with PPI use are examined (chapter 3). The associations between bowel frequency and the primary outcomes of cognitive function measured by cognitive scores and supporting outcomes based on magnetic resonance imaging (MRI) brain structural measures are examined (chapter 4). Finally, the differences in microbial composition and functions associated with bowel frequency and cognitive function are also examined (chapter 5).Conclusions: Overall, the associations between PPI use and cognitive function did not reach statistical significance (chapter 1). We did not observe associations between ALAs and vitamin B12 status. However, the use of metformin alone, or concomitantly with ALAs was inversely associated with baseline serum vitamin B12 concentration. These associations did not extend to long-term medication use (chapter 2). Further, we observed an enrichment of certain microbial taxa and microbial pathways among PPI users compared to PPI non-users (chapter 3). Next, compared to normal bowel frequency, we observed U-shaped and inverse associations between low and high daily bowel frequency and MMSE scores, although these associations did not reach statistical significance with other cognitive or MRI outcomes (chapter 4). Finally, we observed differential enrichment or depletion of certain microbial taxa based on low and high, compared to normal, bowel frequency, but there were no statistically significant microbial differences based on cognitive scores (chapter 5). Our results suggest that metformin use and concomitant use of ALAs and metformin may be inversely associated with serum vitamin B12 concentration, low or high bowel frequency may be associated with general cognitive function, and PPIs and bowel frequency may alter gut microbial composition.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2024

Mode of access: World Wide Web

ISBN: 9798381448399Subjects--Topical Terms:

1180569
Pharmaceutical sciences.
Subjects--Index Terms:

Alzheimer diseaseIndex Terms--Genre/Form:

554714
Electronic books.

Associations Between Medications, Vitamin B12, Gastrointestinal Health, Gut Microbiome and Cognitive Function.
LDR:04596ntm a22003857 4500 001 1151463
005 20241112095329.5
006 m o d
007 cr mn ---uuuuu
008 250605s2024 xx obm 000 0 eng d
020 $a 9798381448399
035 $a (MiAaPQ)AAI30695960
035 $a AAI30695960
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Dinesh, Deepika C. $3 1478235
245 1 0 $a Associations Between Medications, Vitamin B12, Gastrointestinal Health, Gut Microbiome and Cognitive Function.
264 0 $c 2024
300 $a 1 online resource (192 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 85-08, Section: B.
500 $a Advisor: Palacios, Natalia.
502 $a Thesis (Ph.D.)--University of Massachusetts Lowell, 2024.
504 $a Includes bibliographical references
520 $a Introduction: The burden of cognitive impairment is increasing in older adults. Recent estimates report that the largest increase in Alzheimer disease (AD) and related dementias, by 2060, will be among Hispanics and Latinos. Medication use, gastrointestinal (GI) dysfunction and gut dysbiosis are increasingly recognized as modifiable risk factors for cognitive impairment and deficiency of neuroprotective micronutrients, such as vitamin B12. These associations are under-reported in Hispanics and Latinos including Puerto Ricans.Objectives: The broad focus of this dissertation is to examine the associations of medication use, bowel health, gut microbial composition, serum biomarkers of vitamin B12 status, and cognitive function in a prospective cohort of Boston-area Puerto Ricans adults.Methods: This study utilizes cross-sectional and longitudinal data from four waves of data collection over 12 years of follow-up in the Boston Puerto Rican Health Study (BPRHS) among participants aged 45-75 years at baseline. Association between proton pump inhibitors (PPI) and cognitive function (chapter 1), and the associations between acid lowering agents (ALAs, i.e., use of PPIs or histamine type-2 receptor antagonists), metformin use, including long-term medication use, and serum vitamin B12 status are examined (chapter 2). Next, the differences in microbial composition and functions associated with PPI use are examined (chapter 3). The associations between bowel frequency and the primary outcomes of cognitive function measured by cognitive scores and supporting outcomes based on magnetic resonance imaging (MRI) brain structural measures are examined (chapter 4). Finally, the differences in microbial composition and functions associated with bowel frequency and cognitive function are also examined (chapter 5).Conclusions: Overall, the associations between PPI use and cognitive function did not reach statistical significance (chapter 1). We did not observe associations between ALAs and vitamin B12 status. However, the use of metformin alone, or concomitantly with ALAs was inversely associated with baseline serum vitamin B12 concentration. These associations did not extend to long-term medication use (chapter 2). Further, we observed an enrichment of certain microbial taxa and microbial pathways among PPI users compared to PPI non-users (chapter 3). Next, compared to normal bowel frequency, we observed U-shaped and inverse associations between low and high daily bowel frequency and MMSE scores, although these associations did not reach statistical significance with other cognitive or MRI outcomes (chapter 4). Finally, we observed differential enrichment or depletion of certain microbial taxa based on low and high, compared to normal, bowel frequency, but there were no statistically significant microbial differences based on cognitive scores (chapter 5). Our results suggest that metformin use and concomitant use of ALAs and metformin may be inversely associated with serum vitamin B12 concentration, low or high bowel frequency may be associated with general cognitive function, and PPIs and bowel frequency may alter gut microbial composition.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2024
538 $a Mode of access: World Wide Web
650 4 $a Pharmaceutical sciences. $3 1180569
650 4 $a Public health. $3 560998
650 4 $a Medical imaging. $3 1180167
653 $a Alzheimer disease
653 $a Gastrointestinal
653 $a Boston Puerto Rican Health Study
653 $a Magnetic resonance imaging
655 7 $a Electronic books. $2 local $3 554714
690 $a 0572
690 $a 0574
690 $a 0573
710 2 $a ProQuest Information and Learning Co. $3 1178819
710 2 $a University of Massachusetts Lowell. $b Pharmaceutical Sciences. $3 1478236
773 0 $t Dissertations Abstracts International $g 85-08B.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30695960 $z click for full text (PQDT)